Breaking News

Incannex Engages Eurofins to Manufacture Topical Therapeutic ReneCann

ReneCann is Incannex’s proprietary topical cannabinoid formulation for treatment of dermatological conditions caused by immune system disorders.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Incannex Healthcare Ltd., a clinical-stage pharmaceutical company developing medicinal cannabinoid and psychedelic therapies for unmet medical needs, has engaged CDMO Eurofins Scientific to manufacture ReneCann therapeutic for topical applications.   ReneCann is Incannex’s proprietary topical cannabinoid formulation for treatment of dermatological conditions caused by disorders of the immune system, including vitiligo, psoriasis, and atopic dermatitis, otherwise known as eczema. The ReneCann f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters